Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma

Antzeko izenburuak

• Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma
  nork: Helfrich, Iris, et al.
  Argitaratua: (2010)
• Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: One step forward for overcoming anti‐angiogenic drug resistance?
  nork: Helfrich, Iris, et al.
  Argitaratua: (2011)
• Host-Derived Angiopoietin-2 Affects Early Stages of Tumor Development and Vessel Maturation but Is Dispensable for Later Stages of Tumor Growth
  nork: Nasarre, Patrick, et al.
  Argitaratua: (2009)
• Endosialin (Tem1) Is a Marker of Tumor-Associated Myofibroblasts and Tumor Vessel-Associated Mural Cells
  nork: Christian, Sven, et al.
  Argitaratua: (2008)
• The Antiangiogenic 16K Prolactin Impairs Functional Tumor Neovascularization by Inhibiting Vessel Maturation
  nork: Nguyen, Ngoc-Quynh-Nhu, et al.
  Argitaratua: (2011)